China Pharma Holdings CPHI
NYSE CPHI
$0.78 -0.06 (-7.30%)
As of: Sep 9, 2026 · 3:59 PM EDT

China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026)

China Pharma Holdings' (CPHI) quarterly Prepaid Assets came in at $86965.0 in Q2 2026, up 16.16% on a YoY basis from $74869.0 in Q2 2025, and up 17.08% quarter-over-quarter from $74279.0 in Q1 2026.

Analysis

China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026) Analysis & Trends

China Pharma Holdings (CPHI) has reported Prepaid Assets for 13 consecutive years, with $86965.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets rose 16.16% year-over-year to $86965.0; the trailing twelve-month figure through Jun 2026 stood at $86965.0 (up 16.16% YoY), and the FY2025 full-year result was $82368.0, up 1.28% from the prior year.
  • Prepaid Assets advanced to $86965.0 in Q2 2026 per CPHI's latest filing, from $74279.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $268498.0 in Q3 2023 and bottomed at $71788.0 in Q1 2022.
  • Historically, Prepaid Assets has averaged $106550.8 across 5 years, with a median of $87117.0 in 2022.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets soared 207.67% in 2023, then sank 59.57% in 2025.
  • Over 5 years, Prepaid Assets stood at $77697.0 in 2022, then soared by 41.91% to $110258.0 in 2023, then declined by 26.24% to $81328.0 in 2024, then gained by 1.28% to $82368.0 in 2025, then climbed by 5.58% to $86965.0 in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $86965.0, $74279.0, and $82368.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 China Pharma Holdings 31.39 Mn 31.08 Mn 83,566.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86,965.00
Mar 31, 2026 74,279.00
Dec 31, 2025 82,368.00
Sep 30, 2025 75,627.00
Jun 30, 2025 74,869.00
Mar 31, 2025 82,469.00
Dec 31, 2024 81,328.00
Sep 30, 2024 114,202.00
Jun 30, 2024 115,610.00
Mar 31, 2024 203,999.00
Dec 31, 2023 110,258.00
Sep 30, 2023 268,498.00
Jun 30, 2023 117,979.00
Mar 31, 2023 102,774.00
Dec 31, 2022 77,697.00
Sep 30, 2022 87,269.00
Jun 30, 2022 89,935.00
Mar 31, 2022 71,788.00
Dec 31, 2021 58,792.00
Sep 30, 2021 72,805.00